Vaxcyte Inc (NASDAQ: PCVX) on Tuesday, plunged -0.24% from the previous trading day, before settling in for the closing price of $62.39. Within the past 52 weeks, PCVX’s price has moved between $40.00 and $82.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -2.56%. With a float of $102.89 million, this company’s outstanding shares have now reached $108.41 million.
Let’s determine the extent of company efficiency that accounts for 254 employees.
Vaxcyte Inc (PCVX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vaxcyte Inc is 5.09%, while institutional ownership is 91.66%. The most recent insider transaction that took place on Apr 01 ’24, was worth 200,066. In this transaction CHIEF OPERATING OFFICER of this company sold 3,000 shares at a rate of $66.69, taking the stock ownership to the 218,289 shares. Before that another transaction happened on Apr 01 ’24, when Company’s CHIEF EXECUTIVE OFFICER sold 2,616 for $66.71, making the entire transaction worth $174,502. This insider now owns 147,362 shares in total.
Vaxcyte Inc (PCVX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 26.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.56% per share during the next fiscal year.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
Vaxcyte Inc (PCVX) is currently performing well based on its current performance indicators. A quick ratio of 7.54 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.21, a number that is poised to hit -1.13 in the next quarter and is forecasted to reach -4.51 in one year’s time.
Technical Analysis of Vaxcyte Inc (PCVX)
Looking closely at Vaxcyte Inc (NASDAQ: PCVX), its last 5-days average volume was 0.7 million, which is a drop from its year-to-date volume of 0.84 million. As of the previous 9 days, the stock’s Stochastic %D was 30.91%. Additionally, its Average True Range was 2.35.
During the past 100 days, Vaxcyte Inc’s (PCVX) raw stochastic average was set at 41.42%, which indicates a significant increase from 18.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.47% in the past 14 days, which was lower than the 40.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $70.27, while its 200-day Moving Average is $57.10. However, in the short run, Vaxcyte Inc’s stock first resistance to watch stands at $62.79. Second resistance stands at $63.33. The third major resistance level sits at $63.81. If the price goes on to break the first support level at $61.77, it is likely to go to the next support level at $61.29. Now, if the price goes above the second support level, the third support stands at $60.75.
Vaxcyte Inc (NASDAQ: PCVX) Key Stats
Market capitalization of the company is 6.75 billion based on 108,408K outstanding shares. Right now, sales total 0 K and income totals -402,270 K. The company made 0 K in profit during its latest quarter, and -180,800 K in sales during its previous quarter.
